-
Value of Multi-Indication Immunotherapies for the Treatment of Autoimmune Diseases in the United States (US)
Mar 10, 2025, 14:00 PM -
Assessability of Single-Arm Studies (SAT) Under Joint Clinical Assessment (JCA): Whether Drugs Assessed With SAT in the Last Years Would Fit Under the New EU HTA Framework?
Mar 10, 2025, 14:00 PM -
Data Extraction in Literature Reviews Using an Artificial Intelligence Model: Prompt Development and Testing
Mar 10, 2025, 14:00 PM -
Methodological Approaches and Current Applications of Distributed Cost-Effectiveness Analysis: A Systematic Review
Mar 10, 2025, 14:00 PM -
Trends in FDA Approvals of Cardiovascular Drugs from 1980 to 2024
Mar 10, 2025, 14:00 PM -
Is It Time to Rethink Proxy-Reporting? Feasibility and Psychometric Considerations for Creating ObsROs That Adhere to Patient-Focused Drug Development (PFDD) Fit-for-Purpose Guidance
Mar 10, 2025, 14:00 PM -
A Systematic Scoping Review of Published Economic Analyses of Public Cord Blood Banking: Is It Time to Re-Assess?
Mar 10, 2025, 14:00 PM -
Developing a Risk Prediction Model for the Identification of Necrotizing Fasciitis (NF) in Patients
Mar 10, 2025, 14:00 PM -
Costs of Alzheimer's Disease and Related Dementia among Medicare Beneficiaries in the United States
Mar 10, 2025, 14:00 PM -
Drug Pricing Differentials Across Therapy Areas in EU4, UK, and US
Mar 10, 2025, 14:00 PM -
An AI-Powered RAG Based Framework for Data Extractions in Systematic Literature Reviews
Mar 10, 2025, 14:00 PM -
Socioeconomic Evaluation of Breast Cancer Attributable to Benzo[a]pyrene (BaP), Nitrogen Dioxide (NO2), and Polychlorinated Biphenyls 153 (PCB-153) Air Pollutants
Mar 10, 2025, 14:00 PM -
Baseline Risk of Hospitalization and Mortality in High-Risk Subgroups of a Nirmatrelvir/Ritonavir Treatment-Eligible Population With Mild-to-Moderate COVID-19 in the United States: A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Real World Healthcare Resource Utilization (HRU) and Costs Associated With Mantle Cell Lymphoma (MCL) Therapies in the Frontline (1L) and Relapsed/Refractory (R/R) Setting
Mar 10, 2025, 14:00 PM -
Real-World Effectiveness of Alcohol Use Disorder Treatment on Healthcare Utilization and Expenditure Among U.S. Adult Cancer Survivors: A Propensity-Score Matched Cohort Study
Mar 10, 2025, 14:00 PM -
The Impact of Financial Assistance Programs on Medication Adherence: A Systematic Review With AI-Driven Prediction
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of a Hypothetical Dementia Prevention Treatment for Stroke Survivors
Mar 10, 2025, 14:00 PM -
Patient- and Observer-Reported Outcomes with Therapeutic Medical Devices in Children and Adolescents with Obesity: A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Preparing for German Health Technology Assessment: Analysis of Factors Associated with the Risk of Having Inappropriate Comparator
Mar 10, 2025, 14:00 PM -
Assessing the Impact of the United States (US) Inflation Reduction Act (IRA) Regulations on Investment Incentives for Orphan Disease Drug Development
Mar 10, 2025, 14:00 PM
